More so, using the TCGA BLCA cohort (n = 412), we demonstrated that upregulated expression of the med10 gene is positively correlated with several oncogenic miRs (oncomiRs) including hsa-miR-590 (Figure 3B) but is inversely correlated with expression levels of tumor-suppressor miRs, including hsa-miR-483, hsa-miR-29c, hsa-miR-100, and hsa-miR-143 (Figure 3C). The gene discussed is MED10; the disease is neoplasm.